6 studies enrolling now
Each study below is run by a research site and is enrolling now. Read what the study is testing, who it is for and where it takes place. If one fits your situation, Anida can check in a few minutes whether you may qualify. It is free, and taking part is always your choice.
New Depression Relief StudyPhase 3
Testing a new pill that may ease depression when other treatments haven't fully helped.
Major Depression Research StudyPhase 3
Testing a new pill that may help adults with depression feel better without other medications.
This study looks at whether a drug called leflutrozole can help men with low testosterone improve their semen quality and overall fertility. We're testing three different doses to find what works best and to make sure the medication is safe. If you join, you'll receive the study drug and have regular check-ups to monitor your progress.
Who may qualify
These are highlights. The study team confirms full eligibility.
ClinicalTrials.gov NCT06993155
Learn more about this studyThis study is testing whether GB-0895, a new add-on treatment, can better control asthma in people whose symptoms remain serious even while using multiple inhalers. It may help adolescents and adults who have had two or more asthma flare-ups in the past year despite taking high-dose inhaled steroids. Taking part involves being randomly assigned to receive either GB-0895 or a placebo alongside your current asthma medicines.
Who may qualify
These are highlights. The study team confirms full eligibility.
ClinicalTrials.gov NCT07276724
Learn more about this studyThis study tests whether a drug called camlipixant can ease the abdominal discomfort that comes with irritable bowel syndrome, specifically for people with diarrhea-dominant or mixed IBS. If you join, you'll receive either the study drug or a placebo, and part of the study may involve trying a higher dose. Taking part means regular visits to the clinic and keeping track of your symptoms.
Who may qualify
These are highlights. The study team confirms full eligibility.
ClinicalTrials.gov NCT07519395
Learn more about this studyThis study checks whether a new drug called elismetrep works better than placebo to stop migraine attacks as they happen. If you get regular migraines and want to help find better treatments, this may be for you. You'll track your migraines using a smartphone app and visit the clinic a few times over several weeks.
Who may qualify
These are highlights. The study team confirms full eligibility.
ClinicalTrials.gov NCT07645924
Learn more about this studyAnida searches every registered clinical trial, not only the studies listed here. Describe your condition and it will find what matches.
